p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Liver Cancer
0301 basic medicine
Carcinoma, Hepatocellular
Cell Survival
NF-E2-Related Factor 2
Oncology and Carcinogenesis
Chronic Liver Disease and Cirrhosis
Mice, Transgenic
Mechanistic Target of Rapamycin Complex 1
Transgenic
Proto-Oncogene Proteins c-myc
Experimental
Mice
03 medical and health sciences
Rare Diseases
Neoplasms
Sequestosome-1 Protein
Animals
Humans
Diethylnitrosamine
Oncology & Carcinogenesis
Cancer
Neoplastic
Biomedical and Clinical Sciences
Liver Disease
TOR Serine-Threonine Kinases
Carcinoma
Liver Neoplasms
Neurosciences
Hepatocellular
Oncology and carcinogenesis
Neoplasms, Experimental
Up-Regulation
Gene Expression Regulation, Neoplastic
Gene Expression Regulation
Biochemistry and cell biology
Multiprotein Complexes
Neoplastic Stem Cells
Digestive Diseases
DOI:
10.1016/j.ccell.2016.04.006
Publication Date:
2016-05-21T04:27:31Z
AUTHORS (21)
ABSTRACT
p62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs). Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored. Here we show that p62 is necessary and sufficient for HCC induction in mice and that its high expression in non-tumor human liver predicts rapid HCC recurrence after curative ablation. High p62 expression is needed for activation of NRF2 and mTORC1, induction of c-Myc, and protection of HCC-initiating cells from oxidative stress-induced death.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (67)
CITATIONS (391)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....